Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RETIPON: Alpha Lipoic Acid in Diabetic Retinopathy
NCT01208948Phase 3Completed
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Jul 2000
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alpha-lipoic acid in diabetic macular edema (DME), sponsored by Ludwig Maximilian University of Munich. Started Jul 2000; status: completed.
02
Drugs
alpha-lipoic acid
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT01208948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208948.